TP53 and neoplasm: Nutlin-3a (N3a) was the first small molecule reported to specifically inhibit the p53-MDM2 interaction, inducing apoptotic cell death in various types of tumor cells harboring wt-p53, while generating minimal and, mostly, reversible effects in normal cells [2].